10x Science Raises $4.8M to Apply AI to the Bottleneck Slowing Drug Discovery

Y Combinator-backed NewMod, Moritz, formerly Arcline, has raised $9m – including investment from founders from Reddit, Dropbox, HuggingFace, and many more senior tech industry figures. ...

Corgi, a new insurance company backed by Y Combinator, is now offering AI liability insurance – for both the AI companies providing the outputs, and ...

The LinkedIn cofounder now has an AI drug discovery startup—and thinks not asking chatbots for medical advice is “bordering on committing malpractice.”

Artificial intelligence is fundamentally rewiring how medicines are discovered, designed, and brought to market. The CEOs leading this transformation are compressing timelines that once took a decade into years, and in some cases, months. From generative protein design to AI-optimized clinical trials, these leaders are building the platforms that the world’s largest pharmaceutical companies now […]

Soren, which is backed by Y Combinator, has launched what it calls ‘private AI’ aimed at regulated sectors that deal with highly sensitive information. They ...

Garry Tan, the CEO of legendary investor Y Combinator, has waded into the ARR debate over how startups represent their revenues, and demanded that ‘founders ...

April 22, 2026 — 10x Science today announced the closing of its $4.8 million seed round led by Initialized Capital. The oversubscribed round includes investments from Y Combinator, Civilization Ventures, […] The post 10x Science Raises $4.8M Seed to Build AI That Understands Proteins at the Molecular Level appeared first on AIwire.

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.